Immune Checkpoint Inhibitors Market

The global Immune Checkpoint Inhibitors market was valued at 1204.8 Million USD in 2021 and will grow with a CAGR of 16.12% from 2021 to 2027, based on Research newly published report.

The prime objective of Immune Checkpoint Inhibitors Market is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, Immune Checkpoint Inhibitors Market covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoints are activated to suppress the anti-tumor activity of the immune system thereby suppressing the immune response against the cancer cells. The study of these proteins and pathways has led to the development of a number of immune checkpoint inhibitors as therapies against cancer. Initial preclinical studies showed that antibody blockade of the immune checkpoint molecule CTLA-4 resulted in successful anti-tumor immune responses in the murine cancer models. This was then followed by studies targeting the PD-1/PD-L1 pathway. Ipilimumab and Yervoy were the first immune checkpoint inhibitors introduced in the market. With the promising results of Yervoy, several anti-PD-1 and anti-PD-L1 antibodies have been developed. Although there are number of other checkpoints that have been studied, such as LAG-3 and TIM-3, the only approved immune checkpoint inhibitors include CTLA-4, PD-1 and PD-L1.

By Market Verdors:

• Bristol Myer Squibb
• AstraZeneca
• Merck & Co.
• Roche / Genentech
• Incyte Corporation
• NewLink Genetics
• ArGEN-X
• Seattle Genetics
• Pfizer
• MacroGenics
• Celldex Therapeutics
• CureTech
• Immutep
• Innate Pharma
• Sorrento Therapeutics
• GlaxoSmithKline
• GITR, Inc

By Types:

• PD-1/PD-L1
• CTLA-4

By Applications:

• Lung Cancer
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Melanoma
• Blood Cancer

Key Indicators Analysed

• Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
• Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market Trends:

• Market key trends which include Increased Competition and Continuous Innovations.
• Opportunities and Drivers: Identifying the Growing Demands and New Technology
• Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase

• To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
• Assess the production processes, major issues, and solutions to mitigate the development risk.
• To understand the most affecting driving and restraining forces in the market and its impact in the global market.
• Learn about the market strategies that are being adopted by leading respective organizations.
• To understand the future outlook and prospects for the market.
• Besides the standard structure reports, we also provide custom research according to specific requirements.